Filing
Spy
Filing
Spy
Home
About
KRTX — Karuna Therapeutics Inc - FilingSpy
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
2 holders
Ownership
Activity
2023 Q2
3 of 14 quarters
Total Value
$243.91M
Total Shares
1.12M
Net Share Change
-399.7K
Activity
1 buying
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$205.56M
948.0K
0.8%
TRIM
-553.1K
(-36.8%)
Viking Global Investors
$205.56M
948.0K shares
TRIM
-553.1K
(-36.8%)
Patient Capital Management
$38.34M
176.8K
2.1%
ADD
+153.5K
(+656.5%)
Patient Capital Management
$38.34M
176.8K shares
ADD
+153.5K
(+656.5%)